RAB27B and hepatocellular carcinoma: Li and his team found Rab27B was overexpressed and reduced drug concentration in 5-FU resistant HCC cells by encouraging exosome release, while genetic knockdown of Rab27B restored sensitivity to chemotherapy drugs and improved their therapeutic effects (188).